A study of the combination of oxaliplatin, capecitabine, and trastuzumab and chemo-radiotherapy in the adjuvant setting in operated patients with HER2+gastric or gastroesophageal junction cancer (TOXAG study).

Küçük Resim Yok

Tarih

2018

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Lippincott Williams & Wilkins

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

[Abstract Not Availabe]

Açıklama

Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) -- JAN 18-20, 2018 -- San Francisco, CA

Anahtar Kelimeler

[Keyword Not Available]

Kaynak

Journal Of Clinical Oncology

WoS Q Değeri

Q1

Scopus Q Değeri

Q1

Cilt

36

Sayı

4

Künye